Medical Condition

malignant solid neoplasm

Total Trials

12

Recruiting Now

12

Trial Phases

Phase 3, Phase 1

ClinicalMetric tracks all active clinical trials for malignant solid neoplasm sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — malignant solid neoplasm Clinical Trials

How many clinical trials are currently recruiting for malignant solid neoplasm?

ClinicalMetric currently tracks 12 actively recruiting clinical trials for malignant solid neoplasm, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 12. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.

What trial phases are available for malignant solid neoplasm?

malignant solid neoplasm research spans Phase 1 (1 trial), Phase 3 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.

How do I find out if I qualify for a malignant solid neoplasm clinical trial?

Eligibility criteria for malignant solid neoplasm trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.

Trial Phases

Phase 1

Phase 3

Top Sponsors

Mayo Clinic 4 trials

SWOG Cancer Research Network 3 trials

M.D. Anderson Cancer Center 3 trials

City of Hope Medical Center 2 trials

Recruiting Clinical Trials

NCT05772130

Recruiting

Provider-Mediated Communication of Genetic Testing Results to At-Risk Relatives of Cancer Patients to Improve Genetic Counseling and Testing Rates, Family HOPE Study

City of Hope Medical Center

View Trial →

NCT06015932

Recruiting

Group Cognitive Behavior Sessions (CBCSM) to Decrease Distress in Cancer Patients

Immune Checkpoint Inhibitor Toxicity Risk Prediction in Solid Tumors

Enrollment

2,062 pts

Location

United States, Chile...

Sponsor

SWOG Cancer Research Network

View Trial →

NCT07291011

Recruiting

A Mindfulness-Based Stress Reduction Program for Improving Mental Health Outcomes for Underserved Cancer Patients in Minnesota

Aromatherapy Essential Oils to Manage Anxiety and Nausea in Cancer Patients Receiving Infusion in the Ambulatory Setting

City of Hope Medical Center

View Trial →

NCT07278739

Recruiting

Testing an Educational Program to Improve Goals of Care Conversations Between Patients and Their Care Teams

SWOG Cancer Research Network

View Trial →

NCT06640010

Recruiting

Using Induced-Pluripotent Stem Cells to Model Cancer Therapy-Related Adverse Events

Non-invasive Ventilation in Reducing the Need for Intubation in Patients With Cancer and Respiratory Failure

M.D. Anderson Cancer Center

View Trial →

NCT05108519

Recruiting

Complications and Clinical Response in Cancer Patients Treated With Anti-VEGF-Related Therapies

M.D. Anderson Cancer Center

View Trial →

NCT05642611 Phase 3

Recruiting

Comparing Cooling and/or Compression Approaches of Limbs for Prevention of Chemotherapy-Induced Peripheral Neuropathy

SWOG Cancer Research Network

View Trial →

NCT03823144

Recruiting

Intravital Microscopy in Human Solid Tumors

Phase I Study of Tumor Treating Fields (TTF) in Combination With Cabozantinib or With Pembrolizumab and Nab-Paclitaxel in Patients With Advanced Solid Tumors Involving the Abdomen or Thorax

M.D. Anderson Cancer Center

View Trial →

Related Conditions

hematopoietic and lymphatic system neoplasm (3) hematopoietic and lymphoid system neoplasm (2) hematopoietic and lymphoid cell neoplasm (2) anatomic stage iv breast cancer ajcc v8 (2) metastatic breast carcinoma (2) stage iv hepatocellular carcinoma ajcc v8 (2) hereditary malignant neoplasm (1) metastatic malignant solid neoplasm (1) solid tumor adult (1) clinical stage iv gastric cancer ajcc v8 (1) metastatic colorectal carcinoma (1) metastatic gastric carcinoma (1)

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology